Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries. [electronic resource]
- Clinical therapeutics Nov 2017
- 2296-2310.e14 p. digital
Publication Type: Journal Article; Multicenter Study
1879-114X
10.1016/j.clinthera.2017.09.016 doi
Adolescent Adult Aged Body Mass Index Diabetes Mellitus, Type 2--drug therapy Dipeptidyl-Peptidase IV Inhibitors--therapeutic use Drug Therapy, Combination Europe Female Glycated Hemoglobin--analysis Humans Hypoglycemic Agents--therapeutic use Insulin--therapeutic use Male Metformin--therapeutic use Middle Aged Sulfonylurea Compounds--therapeutic use Thiazolidinediones--therapeutic use Young Adult Glucagon-Like Peptide-1 Receptor Agonists